Treatment of brain tumors

New England Journal of Medicine

Volumn 352, Issue 22, 2005, Pages 2350-2353

  Paulino, Arnold C ^a   Teh, Bin S ^a   Sadeh, Michelle ^b   Ashby, Lynn ^c   LaRocca, Renato ^d   Ryken, Timothy ^e   Seiter, Karen ^f   Aiken, Robert D ^g   Rutkowski, Stefan ^h   Ottensmeier, Holger ^h   Pietsch, Torsten ⁱ   Stupp, Roger ^j   Hegi, Monika E ^j   DeAngelis, Lisa M ^k  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Israel Cancer Association   (Israel)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

^d Kentuckiana Cancer Institute   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f NEW YORK MEDICAL COLLEGE   (United States)

^g BETH ISRAEL MEDICAL CENTER   (United States)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ National Reference Center for Brain Tumors   (Germany)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; METHOTREXATE; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; DACARBAZINE; DRUG DERIVATIVE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; HUMAN; LETTER; LEUKOENCEPHALOPATHY; MEDULLOBLASTOMA; NEUROPSYCHOLOGICAL TEST; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; AGE; CEREBELLUM TUMOR; INFANT; NOTE; PATHOLOGY; PRESCHOOL CHILD; BRAIN TUMOR; GENETICS; GLIOBLASTOMA; SURVIVAL; GENE SILENCING; DRUG EFFECT; INTELLIGENCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MORTALITY;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; HUMANS; INFANT; MEDULLOBLASTOMA; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; DACARBAZINE; GLIOBLASTOMA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; SURVIVAL ANALYSIS; GENE SILENCING; SALVAGE THERAPY; INJECTIONS, INTRAVENTRICULAR; INTELLIGENCE; METHOTREXATE; NEUROPSYCHOLOGICAL TESTS;

EID: 19644388733     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM200506023522216     Document Type: Letter

References (0)